That’s the headline number, but the mechanics behind it are what should worry anyone who writes code for a living.
The EFF published its analysis on its Deeplinks blog this week, and Techdirt amplified it: would-be challengers aren’t staying away because software patents got stronger.
In September 2026, just 37 IPR petitions were filed, per USPTO trial statistics, against 129 in December 2024 — the last full month before current USPTO leadership began reshaping how the Board handles challenges. Meanwhile, the institution rate fell from a 66% and 68% band across fiscal years 2022 through 2024 to 41% in fiscal year 2026, which closed in September.
Why the 70% filing collapse matters to developers
Inter partes review, created by Congress, lets a party challenge a questionable patent at the Patent Office instead of fighting an expensive lawsuit in federal court. It exists because patent examiners work under crushing time constraints, and some patents that should never issue do anyway.
Since it came on the scene more than a decade ago, IPRs have helped invalidate bad patents, protecting startups, nonprofits, and independent developers who’d otherwise face litigation costs simply for implementing everyday internet functionality — sending email, using online ads, publishing web pages.
The filing economics only worked because the process was predictable. Preparing a petition means searching for prior art, hiring experts, and developing detailed technical and legal arguments. Expensive? Yes. But cheaper than federal court, and historically rational: petitions that met the standard generally got heard on the merits. That’s exactly what the Q3 2026 petition numbers show.
| Period | IPR petitions filed | Comparison |
|---|---|---|
| Q3 2025 (Jul–Sep) | 327 | Baseline year |
| December 2024 | 129 | Last full month before current leadership |
The Director can now cancel cases already underway
“Institution” — the PTAB agreeing to hear a challenge — has never guaranteed a win. But it did guarantee a full merits review proceeding toward a final written decision. Not anymore.
USPTO leadership has vacated at least 29 institution decisions, subsequently denying the petitions and terminating proceedings before any final decision, per the EFF’s report. Some of those were cases the Board’s own judges had agreed to hear. Others were proceedings the Director himself had previously allowed to proceed. Parties had already invested substantial time and money litigating — only to have the case terminated on reasoning developed after institution.
The precedent case is Revvo Technologies v. Cerebrum Sensor Technologies. The Director vacated an institution decision and remanded it to the Board. The Board then instituted review again. The Director then reversed that, citing inconsistencies between claim construction positions taken before the PTAB and in district court. The EFF notes that decision has since been cited as a basis for terminating several other instituted proceedings.
Who gains when bad patents go unchallenged
Follow the incentives. A patent troll’s business model depends on settlement economics: the cost of defending even a weak patent in district court exceeds the cost of settling. IPR disrupted that calculus by offering a faster, cheaper invalidation path. Remove it, and weak patents become durable weapons again — aimed, as EFF has documented over the years, not just at large tech companies but at people and companies.
Some defenders of the current approach argue lower institution rates simply reflect better balance in the patent system. The counterargument, laid out by EFF, is arithmetic: a drop from as high as 68% to 41% in two years, paired with collapsing petition filings, isn’t selective screening.
The PTAB, formed on September 16, 2012 as part of the America Invents Act, is the administrative law body within the USPTO that decides questions of patentability. It replaced the old Board of Patent Appeals and Interferences and is made up of an Appeals Division with more than 100 Administrative Patent Judges and a Trial Division that handles contested cases like inter partes review.
It is currently headed by Acting Chief Administrative Patent Judge Kalyan K. Deshpande. The Director’s power to overrule the Board traces to the Supreme Court’s 2021 decision in United States v. Arthrex, which found the judges’ appointment unconstitutional and made all PTAB decisions subject to the Director’s review — the very authority now being used to vacate institution decisions.
Confidence in system disappearing as IPRs lose value
Right now, confidence in the system is disappearing. If companies, individuals, and nonprofits conclude IPRs aren’t worth pursuing, more weak patents survive — and the expensive litigation costs IPRs were meant to avoid land right back on the defendants.